General Information of Drug (ID: DMXO3PV)

Drug Name
BI 905681 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMXO3PV

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BI 905677 DMEPJ7C Solid tumour/cancer 2A00-2F9Z Phase 1 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Low-density lipoprotein receptor-related protein 5 (LRP5) TT7VMG4 LRP5_HUMAN Antagonist [2]

References

1 ClinicalTrials.gov (NCT04147247) A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Boehringer Ingelheim.